Dissociation of the effects of intramedullary monoamine neurotoxins on the hypotensive action of moxonidine and on immunodetected imidazoline and alpha 2-receptor proteins.
Head
G A
GA
Baker Medical Research Institute, Melbourne, Victoria, Australia.
Chan
C K
CK
Zhu
H
H
Piletz
J E
JE
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D007093:Imidazoles / Q000494:pharmacology*; D054755:Imidazoline Receptors; D007276:Injections, Intraventricular; D008526:Medulla Oblongata / Q000187:drug effects / Q000502:physiology*; D009498:Neurotoxins / Q000008:administration & dosage / Q000633:toxicity; D016627:Oxidopamine / Q000008:administration & dosage / Q000633:toxicity*; D011817:Rabbits; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects / Q000502:physiology*; D011955:Receptors, Drug / Q000187:drug effects / Q000502:physiology*
D000959:Antihypertensive Agents; D007093:Imidazoles; D054755:Imidazoline Receptors; D009498:Neurotoxins; D018341:Receptors, Adrenergic, alpha-2; D011955:Receptors, Drug; D016627:Oxidopamine; C043482:moxonidine